The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: The updated follow up at 78 months

Transplant Immunology

Volumn 20, Issue 1-2, 2008, Pages 43-47

  Orlando, Giuseppe ^b,c   Manzia, Tommaso ^a   Baiocchi, Leonardo ^a   Sanchez Fueyo, Alberto ^d   Angelico, Mario ^a   Tisone, Giuseppe ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

HCV recurrence; Immunosuppression; Liver transplant; Quality of life; Tolerance; Weaning

Indexed keywords

ALLOPURINOL; BISPHOSPHONIC ACID DERIVATIVE; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; LEVOTHYROXINE; LIPID; NEUROLEPTIC AGENT; VIRUS RNA;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEASIBILITY STUDY; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER GRAFT; LIVER GRAFT REJECTION; LUNG CARCINOMA; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; RECURRENT INFECTION; VIRUS INFECTION;

DISEASE PROGRESSION; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; RECURRENCE;

EID: 56049120306     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.08.007     Document Type: Article

References (52)

1. Tisone G., Orlando G., Cardillo A., Palmieri G., Manzia T., Baiocchi L., et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol 44 (2006) 702-709
2. Devlin J., Doherty D., Thomson L., Wong T., Donaldson P., Portmann B., et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 27 (1998) 926-933
3. Mazariegos G.V., Sindhi R., Thomson A.W., and Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 17 (2007) 114-119
4. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
5. Snover D.C., Freese D.C., Sharp H.L., Bloomer J.R., Najaran J.S., and Ascher N.L. Liver allograft rejection: an analysis of the use of biopsy in determining the outcome of rejection. Am J Surg Pathol 11 (1987) 1-10
6. Rimola A., Londoño M.C., Guevara G., Bruguera M., Navasa M., Forns X., et al. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation 78 (2004) 686-691
7. Neumann U.P., Berg T., Bahra M., Puhl G., Guckelberger O., Langrehr J.M., et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation 77 (2004) 226-231
8. Berenguer M. Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl 9 Suppl. 3 (2003) S44-S47
9. Lake J.R. The role of immunosuppression in the recurrence of hepatitis C. Liver Transpl 9 Suppl. 3 (2003) S63-S66
10. Wiesner R.H., Sorrell M., Villamil F., and the International Liver Transplantation Society Expert Panel. Report of the first international liver transplantation expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 9 Suppl. 3 (2003) S1-S9
11. Reyes J., Zeevi A., Ramos H., Tzakis A., Todo S., Demetris A.J., et al. Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 25 (1993) 3315-3319
12. Ramos H.C., Reyes J., Abu-Elmagd K., Zeevi A., Reinsmoen N., Tzakis A., et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 59 (1995) 212-217
13. Mazariegos G.V., Reyes J., Marino I.R., Demetris A.J., Flynn B., Irish W., et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 63 (1997) 243-249
14. VanBuskirk A.M., Burlingham W.J., Jankowska-Gan E., Chin T., Kusaka S., Geissler F., et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 106 (2000) 145-155
15. Geissler F., Jankowska-Gan E., DeVito-Haynes L.D., Rhein T., Kalayoglu M., Sollinger H.W., et al. Human liver allograft acceptance and the "tolerance assay": in vitro anti-donor T cell assays show hyporeactivity to donor cells, but unlike DTH, fail to detect linked suppression. Transplantation 72 (2001) 571-580
16. Takatsuki M., Uemoto S., Inomata Y., Sakamoto S., Hayashi M., Ueda M., et al. Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. Transpl Immunol 8 (2001) 279-286
17. Takatsuki M., Uemoto S., Inomata Y., Egawa H., Kiuchi T., Fujita S., et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72 (2001) 449-454
18. Tisone G., Orlando G., and Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Immunol 17 (2007) 108-113
19. Karam V.H., Gasquet I., Delvart V., Hiesse C., Dorent R., Danet C., et al. Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation. Transplantation 76 12 (2003) 1699-1704
20. Saliba F., Lakehal M., Pageaux G.P., Roche B., Vanlemmens C., Duvoux C., et al. Diapason Study Group. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl 13 (2007) 136-144
21. Martínez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., et al. Towards a diagnostic test of operational tolerance in liver transplantation employing transcriptional profiling. J Clin Invest 118 (2008) 2845-2857
22. Martínez-Llordella M., Puig-Pey I., Orlando G., Tisone G., Ramoni M., Lerut J., et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transpl 7 (2007) 309-319
23. Seyfert-Margolis V., and Turka L.A. Marking a path to transplant tolerance. J Clin Invest 118 (2008) 2684-2686
24. Li Y., Koshiba T., Yoshizawa A., Yonekawa Y., Masuda K., Ito A., et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4 (2004) 2118-2125
25. Koshiba T., Li Y., Takemura M., Wu Y., Sakaguchi S., Minato N., et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 17 (2007) 94-97
26. Ashton-Chess J., Giral M., Brouard S., and Soulillou J.P. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 84 (2007) 1215-1219
27. Merrill J.P., Murray J.E., and Harrison J.H. Successful homotransplantation of the human kidney between identical twins. JAMA 160 (1956) 277-282
28. Urban C.H., Deutschmann A., Kerbl R., Lackner H., Schwinger W., Königsrainer A., et al. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 30 (2002) 535-537
29. Mazariegos G.V., Zahorchak A.F., Reyes J., Ostrowski L., Flynn B., Zeevi A., et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3 (2003) 689-696
30. Starzl T.E., Murase N., Abu-Elmagd K., Gray E.A., Shapiro R., Eghtesad B., et al. Tolerogenic immunosuppression for organ transplantation. Lancet 361 9368 (2003) 1502-1510
31. Kadry Z., Mullhaupt B., Renner E.L., Bauerfeind P., Schanz U., Pestalozzi B.C., et al. Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma. Transplantation 76 (2003) 1003-1006
32. Pons J.A., Yélamos J., Ramíírez P., Oliver-Bonet M., Sánchez A., Rodríguez-Gago M., et al. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation 75 (2003) 1045-1047
33. Donckier V., Troisi R., Toungouz M., Colle I., Van Vlierberghe H., Jacquy C., et al. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft. Transpl Immunol 13 (2004) 139-146
34. Li Y., Koshiba T., Yoshizawa A., Yonekawa Y., Masuda K., Ito A., et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 4 (2004) 2118-2125
35. Tryphonopoulos P., Tzakis A.G., Weppler D., Garcia-Morales R., Kato T., Madariaga J.R., et al. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant 5 (2005) 608-613
36. Mazariegos G.V., Zahorchak A.F., Reyes J., Chapman H., Zeevi A., and Thomson A.W. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 5 (2005) 314-322
37. Eason J.D., Cohen A.J., Nair S., Alcantera T., and Loss G.E. Tolerance: is it worth the risk?. Transplantation 79 (2005) 1157-1159
38. Girlanda R., Rela M., Williams R., O'Grady J.G., and Heaton N.D. Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc 37 (2005) 1708-1709
39. Yoshizawa A., Ito A., Li Y., Koshiba T., Sakaguchi S., Wood K.J., et al. The roles of CD25+CD4+ regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc 37 (2005) 37-39
40. Donckier V., Troisi R., Le Moine A., Toungouz M., Ricciardi S., Colle I., et al. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion. Liver Transpl 12 (2006) 1523-1528
41. Hsu L.W., Goto S., Nakano T., Lai C.Y., Lin Y.C., Kao Y.H., et al. Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants. Transpl Immunol 17 (2007) 137-146
42. Mazariegos G.V., Sindhi R., Thomson A.W., and Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 17 (2007) 114-119
43. Koshiba T., Li Y., Takemura M., Wu Y., Sakaguchi S., Minato N., et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 17 (2007) 94-97
44. Craciun L., Stordeur P., Troisi R., Le Moine A., Toungouz M., Colle I., et al. A rapid test of alloreactivity based on interleukin-2 mRNA expression might identify liver transplant recipients with donor-specific hyporesponsiveness. Transplant Proc 39 (2007) 2665-2667
45. Assy N., Adams P.C., Myers P., Simon V., Minuk G.Y., Wall W., et al. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation 83 (2007) 1571-1576
46. Assy N., Adams P.C., Myers P., Simon V., and Ghent C.N. A randomised controlled trial of total immunosuppression withdrawal in stable liver transplant recipients. Gut 56 (2007) 304-306
47. Alexander S.I., Smith N., Hu M., Verran D., Shun A., Dorney S., et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 358 (2008) 369-374
48. Tokita D., Mazariegos G.V., Zahorchak A.F., Chien N., Abe M., Raimondi G., et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 85 (2008) 369-377
49. Gras J., Wieërs G., Vaerman J.L., Truong D.Q., Sokal E., Otte J.B., et al. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 13 (2007) 426-433
50. Matthes-Martin S., Peters C., Königsrainer A., Fritsch G., Lion T., Heitger A., et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 96 (2000) 3997-3999
51. Mellgren K., Fasth A., Saalman R., Olausson M., and Abrahamsson J. Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia. Ann Hematol 84 (2005) 755-757
52. Andreoni K.A., Lin J.I., and Groben P.A. Liver transplantation 27 years after bone marrow transplantation from the same living donor. N Engl J Med 350 (2004) 2624-2625